Nasal NAD+ for Focus: Is There Evidence?

Nasal NAD+ sprays are marketed with the promise that bypassing the gut delivers a faster, sharper boost to focus and mental energy. It's a compelling pitch. The problem is that the specific evidence for it doesn't exist. This page is short and direct: here's what's actually been studied, what hasn't, and what we can reasonably say about safety.

The Core Evidence Gap

There is **no rigorous randomized trial of intranasal NAD+ for cognition or energy**. Not a weak one — none. Nasal NAD+ for focus is essentially unstudied in humans. That's the single most important fact on this page, and it doesn't change no matter how confident a product's marketing sounds.

It's worth being precise about what *does* exist for non-oral routes, because it's so often overstated. The only human parenteral-NAD+ data is a small pilot study that characterized the pharmacokinetics of a 6-hour intravenous NAD+ infusion — it tracked how NAD+ and its metabolites moved through plasma and urine¹. Critically, that pilot measured **no cognitive or focus outcomes at all**. It was designed to answer "where does the NAD+ go?", not "does it make you think better?" So even for IV NAD+ — a far more studied route than nasal — the human literature is preliminary and pharmacokinetic. For nasal NAD+ specifically, there isn't a comparable rigorous study to point to at all. A spray marketed "for focus" is therefore making a claim the science hasn't tested, in either direction.

It's also worth naming the route problem directly. Marketing for nasal and IV products often implies that "bypassing the gut" makes them more effective. But absorption is not efficacy. Delivering a molecule more efficiently to the bloodstream tells you nothing about whether it improves cognition once it's there — and as the cognition data below show, the route that *has* been tested for both delivery and thinking didn't deliver a cognitive benefit anyway.

Why "It Raises NAD+" Isn't Enough

The strongest thing the NAD+ field can demonstrate is that precursors raise the NAD+ biomarker — and even that's been shown mainly for *oral* forms in controlled trials, not validated for nasal delivery. But raising NAD+ doesn't establish a focus benefit. The best-controlled human cognition study in this space used oral NR in older adults with mild cognitive impairment: NAD+ went up, and cognition did not improve versus placebo². In other words, the route that *has* been studied for both biomarker and cognition showed the biomarker can rise while thinking stays flat. There's no reason to assume a nasal spray clears that bar when the oral evidence — which actually measured cognition — didn't. If anything, the nasal route has a steeper hill to climb, because it adds an unproven delivery method on top of an unproven cognitive effect.

What About Safety?

Safety and efficacy are separate questions. On the safety side, oral precursors look reasonably benign: a randomized high-dose nicotinamide riboside trial found it generally safe and well tolerated over the study period³. That's reassuring for *oral NR* — but it tells us nothing about the safety of nasal or injectable NAD+, which haven't been characterized the same way. "Oral NR was tolerated" should never be read as "this nasal spray is proven safe and effective for focus."

The Honest Bottom Line

Nasal NAD+ for focus sits in an evidence vacuum: no efficacy trials, no cognitive outcomes even from the IV route, and safety data that only covers oral precursors. If a product implies a nasal spray will sharpen your focus, that claim runs ahead of the data — and being told the truth here is more useful than being sold a result that hasn't been measured.

None of this means NAD+ biology is fake or that nasal delivery could never work; it means the studies that would justify a focus claim simply haven't been done. Until they are, the responsible read is that nasal NAD+ for focus is unproven, full stop. If you're weighing one of these products, the right question isn't "does it raise NAD+?" but "is there a human trial showing it improves the outcome I actually care about?" — and for the nasal route, the answer today is no.

For what the broader NAD+ evidence actually shows — including why raising NAD+ hasn't translated to proven cognitive benefit, and what does have evidence for clearer thinking — see the pillar guide, NAD+, Brain Fog & Focus: What the Evidence Shows.